Domov › Rakovina krvi › Maryland › Baltimore
Klinické štúdie Rakovina krvi v meste Baltimore, MD
18 štúdií pre Rakovina krvi hľadá účastníkov v zariadeniach v meste Baltimore a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.
Oficiálny text štúdie (anglicky)
Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
Prebieha náborFáza 3
- MedStar Franklin Square Medical Center ( Site 0046), Baltimore
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins ( Site 0056), Baltimore
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
- Mercy Medical Center, Baltimore
- Sinai Hospital of Baltimore, Baltimore
- MedStar Franklin Square Medical Center/Weinberg Cancer Institute, Baltimore
- a 2 ďalších
Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
Prebieha náborSkorá fáza 1
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
Prebieha náborFáza 3
- Quetzal Site 23, Baltimore
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Prebieha náborFáza 1
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
Prebieha náborFáza 3
- Johns Hopkins Asthma & Allergy Center, Baltimore
Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
Prebieha náborObservačná štúdia
- UM Saint Joseph Medical Center, Towson · 8 míľ odtiaľ
Alteplase Through an Indwelling Pleural Catheter for the Management of Symptomatic Septated Malignant Pleural Effusion
Prebieha náborSkorá fáza 1
- John Hopkins University, Baltimore
Multi-institutional Prospective Research of Expanded Multi-antigen Specifically Oriented Lymphocytes for the Treatment of VEry High Risk Hematopoietic Malignancies
Prebieha náborFáza 1
- Tania Jain, MD, Baltimore
PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV)
Prebieha náborFáza 2
- Johns Hopkins Hospital, Baltimore
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Prebieha náborObservačná štúdia
- Johns Hopkins, Baltimore
Take the Reins: The Effects of Nutrient Timing on Cancer-related Fatigue
Prebieha náborFáza 2
- University of Maryland, Baltimore, Baltimore
Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
Prebieha náborObservačná štúdia
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients
Prebieha náborFáza 3
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Prebieha náborFáza 1
- Johns Hopkins School of Medicine, Baltimore
Ocular Complications From Cancer Therapy - Patient Registry and Biobank
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
- Stoler Outpatient Cancer Center at the University of Maryland, Baltimore
A Study for Participants Previously Treated With Century Therapeutics Cellular Therapy Product
Prebieha náborObservačná štúdia
- University of Maryland Medical Center, Baltimore
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
Prebieha náborFáza 1
- Johns Hopkins University, Baltimore
Štúdie Rakovina krvi v iných mestách
- Houston, TX46 štúdií
- New York City, NY26 štúdií
- Boston, MA25 štúdií
- Washington, DC19 štúdií
- Seattle, WA18 štúdií
- Los Angeles, CA17 štúdií
- Durham, NC16 štúdií
- Chicago, IL15 štúdií
- Philadelphia, PA14 štúdií
- Atlanta, GA13 štúdií
- Nashville, TN13 štúdií
- Edison, NJ13 štúdií
Iné štúdie v Baltimore
- Nemalobunkový karcinóm pľúc60 štúdií
- Rakovina prsníka47 štúdií
- Rakovina prostaty43 štúdií
- Rakovina pľúc40 štúdií
- Rakovina (všetky typy)37 štúdií
- Kolorektálny karcinóm31 štúdií
- Rakovina pankreasu31 štúdií
- Metastatická rakovina28 štúdií
- Obézita25 štúdií
- Srdcové zlyhanie24 štúdií
- Rakovina močového mechúra24 štúdií
- Cievna mozgová príhoda22 štúdií
Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.